Rituximab for late onset myasthenia gravis: Evidence mounting but deliberations continue

Muscle Nerve. 2020 Sep;62(3):297-299. doi: 10.1002/mus.26998. Epub 2020 Jul 6.

Authors

Michael K Hehir¹, Yuebing Li²

Affiliations

¹ Department of Neurological Sciences, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
² Neuromuscular Center, Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA.

PMID: 32530500
DOI: 10.1002/mus.26998

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Myasthenia Gravis*
Receptors, Cholinergic
Rituximab

Substances

Receptors, Cholinergic
Rituximab